This course has been developed by physicians who had recently participated in the writing of the ECCO Crohn's disease consensus Guidelines. This course is intended for those who are interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to Perianal disease in order to improve patient outcomes.

After this case you will:

• To appreciate the Crohn’s disease natural history
• To appreciate the rationale behind specific treatment decisions
• To understand the right investigations to prescribe to Crohn’s disease patient in specific settings
• To learn appropriate clinical management of Crohn’s disease patients with perianal involvement

This course has been developed by physicians who had recently participated in the writing of the ECCO Crohn's disease consensus Guidelines. This course is intended for those who are interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to Luminal disease in order to improve patient outcomes.

Upon completion of this case you will:

• Know the evidence for induction of remission in mild-to-moderate Crohn’s disease;
• Know the evidence for maintaining remission in  Crohn’s disease;
• Know the evidence on how to react upon disease flares, immediately after induction therapy or during maintenance therapy; 
• Understand the benefits and risks of several medical therapies;
• Achieve familiarity how to use immunomodulatory agents in mono- or combination therapy;
• Achieve familiarity how to monitor Crohn’s disease patients who initiated medical therapy or who underwent surgery;
• Recognise indications for surgical management.

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to IBD and Malignancies and to harmonise diagnostics and treatment in order to improve patient outcomes.

This course will follow the following cases on:

1. Colorectal cancer in IBD
   
2. Lymphoma risk following immunosuppressive therapy with thiopurines in IBD patients - cancer and IBD
   
3. Skin cancer in IBD
4. Chemotherapy in chronically active ulcerative colitis

Upon completion of this activity learners will have gained knowledge on:

• IBD and Solid Tumours
  
• IBD and Haematological Malignancies
  
• IBD and Skin Malignancies
• Management of IBD patients with a past history of malignancy

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the prediction, diagnosis and management of stricturing Crohn's Disease (CD) patients and to harmonise diagnostics and treatment in order to improve patient outcomes.

Upon completion of this activity learners will:

• Achieve familiarity with predictors of fibrostenosing CD.

• Understand the role of cross-sectional imaging in the diagnostic work-up of patients with suspected fibrostenosing CD.
• Understand the current management of fibrostenosing CD.
• Recognise the therapeutic capabilities of anti-inflammatory therapy, endoscopic dilatation and surgery in the setting of fibrostenosing CD.

This course has been developed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the management of CD patients and to harmonise indications and technical considerations for surgery in order to improve patient outcomes.

Upon completion of this activity learners will:

• - Know how to identify surgical indications in patients with Crohn's Disease (CD)
  
• - Be able to adequately treat different complications in CD patients that require surgery
  
• - Be able to recommend appropriate changes in perioperative treatment and management

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the prediction, diagnosis and management of Ulcerative Colitis (UC) patients and to harmonise diagnostics and treatment in order to improve patient outcomes.

Upon completion of this activity learners will:

• Have insights into the basic epidemiology of ulcerative colitis
• Know current treatment options for severe ulcerative colitis, including colectomy
• Be able to use ciclosporin correctly in severe ulcerative colitis
• Understand when to order thiopurine methyltransferase (TPMT) activity when starting azathioprine

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). The intended result of this activity is increased competence, knowledge, performance and improved patient outcomes.

Upon completion of this activity learners will:

• Have insights into the position of surgery versus medical therapy in patients with moderate-to-severe as well as acute severe IV steroid refractory colitis (UC)
• Be able to select the most optimal surgical modalities
• Gain knowledge on the appropriate follow-up of patients with an ileal pouch-anal anastomosis (IPAA)